Tom Yan, MD
Pulmonary Disease · Silverdale, WANPI 1962515742
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 98.7% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $5,251, more than ten times the $68 reported in 2019.
Across 20 payments — averaging $424.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- GSK$68
- Insmed, Inc.$42
What the payments were for
- Travel & lodging$3,70444%
- Food & beverage$7819%
- Education$4,00047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $8,375 |
| GSK | 1 | $68 |
| Insmed, Inc. | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,036
- DA VINCI SP$1,240
How this compares
$8,486 in reported general payments places this provider in the 85th percentile of 275 pulmonary disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 381 | $215,313 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 206 | $169,527 |
| TezspireTezepelumab-Ekko | 22 | $99,483 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 117 | $84,784 |
| Spiriva RespimatTiotropium Bromide | 95 | $67,168 |
| Dupixent PenDupilumab | 14 | $58,699 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $26,285 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $20,083 |
| SymbicortBudesonide/Formoterol Fumarate | 59 | $17,045 |
| Incruse ElliptaUmeclidinium Bromide | 23 | $13,440 |
| DuleraMometasone/Formoterol | 33 | $13,009 |
| Arnuity ElliptaFluticasone Furoate | 41 | $12,469 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $6,470 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 279 | $6,257 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 32 | $4,825 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $68 | $437,034699 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 275 pulmonary disease providers in Washington.
Other pulmonary disease in Silverdale
- Kittredge BaldwinSilverdale$10K
- Jed GordenSeattle$236K
- Dominique PepperOlympia$212K
- Jiten PatelSpokane$200K
- Oneil BainsSeattle$156K
- Ganesh RaghuSeattle$147K
- Nicholas WyshamVancouver$117K
- Colleen OverdorfBellingham$110K
- Jeffrey CarySeattle$106K
- Benjamin SyBremerton$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.